'Heartmate ii' presentation slideshows

Kelsey Flint, MD University of Colorado School of Medicine Division of Cardiology

Global and Disease-Specific Health Status in Patients U ndergoing C ontinuous-Flow L eft V entricular Assist Device Placement. Kelsey Flint, MD University of Colorado School of Medicine Division of Cardiology General Cardiology Fellow. Survival after LVAD.

364 views • 36 slides

PREVEN tion of Pump T hrombosis Through Clinical Management (PREVENT)

PREVEN tion of Pump T hrombosis Through Clinical Management (PREVENT). John M. Stulak, MD Mayo Clinic. INTRODUCTION: Study Background. Confirmed thrombus at 3 Months 2.2% before March 1, 2011 8.4% after M arch 1, 2011 ~15% predicted into 2013 and exponentially rising.

253 views • 25 slides

Mandeep R. Mehra, MD, Daniel J. Goldstein, MD, Nir Uriel, MD, Joseph C. Cleveland, Jr., MD ,

258 views • 24 slides

Risk Factors for Adverse Outcome after HeartMate II

Risk Factors for Adverse Outcome after HeartMate II. Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana Advanced Heart Failure, Transplant, & Mechanical Circulatory Support. Relevant Financial Relationship Disclosure Statement. Jennifer A Cowger, MD, MS

247 views • 24 slides

Ventricular Assist Devices

Ventricular Assist Devices. Topics in Bioengineering. Increasing use of VADs as bridge to transplantation. Klotz et al. (2008) Prog Biophys Mol Biol. Overview of VAD types.

424 views • 22 slides